Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02307188 · ClinicalTrials.gov registry record · NA
Multipolar Mapping and Atrial Arrhythmias
A NA study of Atrial Fibrillation or Atrial Flutter, sponsored by Angelo Biviano.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT02307188 is a NA study of Atrial Fibrillation or Atrial Flutter that has completed, run by Angelo Biviano. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02307188, a NA study of Atrial Fibrillation or Atrial Flutter, has completed, sponsored by Angelo Biviano.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical investigation utilizes the Constellation Full Contact Mapping catheter in the left and right atria to explore atrial signal characteristics that can guide atrial fibrillation and atrial flutter ablation procedures more effectively.
Conditions Studied
Interventions
- DEVICE Constellation Full Contact Mapping Catheter
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02307188
The ClinicalTrials.gov registry entry for NCT02307188 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Angelo Biviano, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation or Atrial Flutter appearing as the primary indexed condition, and to 1 intervention - of which Constellation Full Contact Mapping Catheter is the first listed.
NCT02307188 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02307188 about?
NCT02307188 is a clinical study titled "Multipolar Mapping and Atrial Arrhythmias". This clinical investigation utilizes the Constellation Full Contact Mapping catheter in the left and right atria to explore atrial signal characteristics that can guide atrial fibrillation and atrial flutter ablation procedures more effectively.
What is the current status of trial NCT02307188?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2014-11. Estimated completion is 2015-12.
What conditions does trial NCT02307188 study?
This clinical trial studies the following conditions: Atrial Fibrillation or Atrial Flutter.
What interventions are being tested in trial NCT02307188?
The interventions under investigation include: Constellation Full Contact Mapping Catheter (DEVICE).
Who is sponsoring clinical trial NCT02307188?
This trial is sponsored by Angelo Biviano, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02307188 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.